RPG Life Sciences reports 37.6% YoY growth in Q4 FY23 profit.

RPG Life Sciences

For the quarter ended March FY, RPG Life Sciences – a manufacturer of medical products, recorded a 37.6% year-on-year growth in profit at Rs 10.35 crore while revenue rose 14.1% to Rs 118.5 crore on in the same third year. Margins expanded 17.8% yoy to Rs 15.91 crore in the quarter ended March at 13.42%. In addition, the company announced a dividend of Rs 12 per share in FY23.